fda status bpc 157 2026 Peptide Reclassification 2026: What It Means for Providers NBC News | The claims

Cagrilintide vs retatrutide Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

The peptide shows particular promise for inflammatory bowel conditions

A physician at one clinic who voted yes framed it directly: "As a physician, I have to make sure that I'm keeping patients as safe as possible." Pushing these compounds entirely underground does not accomplish that

If fatigue arrives with shakiness, sweating, confusion, palpitations, or unusual hunger, people with diabetes should follow their clinicians glucose plan and seek medical guidance

By activating these receptor systems, researchers can investigate mechanisms involved in satiety signaling and metabolic regulation